Companies: 10,795·Total market cap: $144.5T

Evolva Holding S.A.

Evolva Holding S.A.

ELVAYOTCHealthcare

$1.16

+$0.00(+0.00%)

Market Cap$518242

P/E Ratio—

52W High$1.71

52W Low$0.8983

Avg Volume1

Open$1.16

Beta0.67

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Evolva Holding S.A.（ELVAY）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · ELVAY · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-19.66Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)$4.2MFull revenue history

Dividend Yield7.91%Dividend history

Shares Outstanding7.2MShares outstanding history

Next EarningsTBAEarnings history

探索 Evolva Holding S.A. 数据

分析师预测—

营收—-100.00%

盈利EPS $0.14+100.72%

财务快照

FY 2024Revenue$0.00▼ 100.00% YoY

202220232024

FY 2024Net Income$1.0M▲ +100.99% YoY

202220232024

FY 2024EPS$0.14▲ +100.72% YoY

202220232024

TTM:Revenue: $4.2MNet Income: -$100.4MEPS: $-19.66View income statement →

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Evolva Holding S.A.

$1.16+0.00%$518,242 #2

Alseres Pharmaceuticals, Inc.

$0.01+100.00%$398,255 #3

Claritas Pharmaceuticals, Inc.

$0.00+0.00%$3,659 #4

$0.00+0.00%$0 #5

TuHURA Biosciences, Inc.

$2.05+4.07%$130.2M #6

Laxai Pharma, Ltd.

$0.00+0.00%$475,341

股票表现

1D+0.00%

1W+0.00%

1M+0.00%

3M+0.00%

YTD+0.00%

1Y+0.00%

5Y+0.00%

关于 Evolva Holding S.A.

CEOChristian Wichert

IPO DateFeb 4, 2014

Employees50

CountryCH

Websiteevolva.com

Evolva Holding S.A. Evolva Holding SA is a Swiss-headquartered firm, established in 2004, that operates internationally, including in the United States. The company focuses on identifying, scientifically exploring, advan…

Biotechnology HealthcareOTCADRCH

关于股票概览与关键数据

Evolva Holding S.A.（ELVAY）是 Biotechnology 行业的 Healthcare 类公司，于 Feb 4, 2014 在 OTC 上市。截至最近交易日，ELVAY 股价为 $1.16，市值约为 $518,242。过去12个月累计回报 +0.00%，年初至今回报 +0.00%。

2024 财年 Evolva Holding S.A. 营收 —。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。

常见问题

截至最近一个交易日，Evolva Holding S.A.（ELVAY）股价为 $1.16，在 OTC 上市，52周区间为 $0.90 – $1.71。

ELVAY 最新股价ELVAY quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议